Recon: Novo Nordisk to slash Wegovy price by as much as 37% in India; Neurocrine depression therapy fails in mid-stage study

• The $10 billion question: Will Pfizer hit it big with Metsera, or have regrets? (STAT)
• What Pfizer’s Metsera deal means for biotech M&A (STAT)
• New Rules, New Risks: Inside the Changing World of Federal Inspections (FDA Law Blog)
• US Health Care Premium Spikes to Squeeze Main Street Businesses (Bloomberg)

• China’s biotech boom is being driven by a dazzling market rebound (STAT)
• U.K. releases plan to phase out animal testing in research (STAT)
• South Africa Starts Trial of First Self-Made Vaccine in 50 Years (Bloomberg)
• Novo Nordisk cuts Wegovy price by up to 37% in India (Reuters)
• India's JB Chemicals & Pharmaceuticals posts profit jump on strong domestic demand (Reuters)
• UNICEF says Israel blocking one million syringes needed to vaccinate Gaza children (Reuters)

• Merck’s pill to reduce cholesterol on top of statins matches results from injectables (STAT)
• EnGene posts more pivotal data for bladder cancer gene therapy, plans 2026 filing (Endpoints)
• Neurocrine reports Phase 2 fail for depression drug it licensed from Takeda (Endpoints)
• Novo Nordisk posts mixed mid-stage data on cardiomyopathy drug with new mechanism (Endpoints)
• Drugmakers Pile Into a Cancer Gold Rush With Questionable Payoff (Bloomberg)
• Neuberg Diagnostics Said to Eye $350 Million India IPO in 2026 (Bloomberg)
• Kezar Loses 70% of Staff After FDA Cancels Meeting on Autoimmune Asset (BioSpace)
• AstraZeneca hits record high, cements lead as UK's biggest stock (Reuters)
• Despite Obesity Drug Pricing Deal, GLP-1 Compounders Continue To Operate in the Shadows (BioSpace)

• Medicare will pay more than $1,000 for AI to analyze a heart scan. Is that too much? (STAT)
• Health IT startup Fabric buys UCM Digital Health — its 5th acquisition in 3 years (Endpoints)
• Can Chatbots Treat Depression? FDA Advisers Urge Caution on Generative AI Tools (MedTech Insight)
• BCI Maker INBRAIN Inks Deal With Microsoft To Explore Agentic AI Use For Monitoring Patients (MedTech Insight)
• Prosthetics: Firms Like Unhindr And Esper Shape Market On the Cusp of Great Change (MedTech Insight)
• Deals Shaping The Medtech And Diagnostics Industries, October 2025 (MedTech Insight)

• TreeHouse Foods to be acquired for $2.9B (Food Dive)
• Salmonella in sprouts sickens 44 in Australia (Food Safety News)
• Australian firm fined for causing botulism illness (Food Safety News)
• Researchers say Listeria biofilms are particularly dangerous (Food Safety News)

• Jury gives Novo Nordisk a win in decade-long hemophilia fraud case (Endpoints)
• Activists Assemble for Big M&A Push in US (Bloomberg)